Opthea

+$0.36 (+4.04%) Today
-$0.08 (-0.86%) As of 8:00 PM UTC after-hours

Why Robinhood?

You can buy or sell Opthea and other stocks, options, and ETFs commission-free!

About OPT

Opthea Limited American Depositary Shares, also called Opthea, is a clinical stage biopharmaceutical company that engages in the development of biological therapeutics for the treatment of progressive retinal diseases. It targets to treat neovascular age-related macular degeneration (wet AMD) and diabetic macular edema, which causes visual impairment among elderly and diabetic patients.

CEO
Megan Baldwin, PhD
Employees
—
Headquarters
South Yarra, Victoria (VIC)
Founded
1984

OPT Key Statistics

Market Cap
390.83M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
4.55K
High Today
$9.60
Low Today
$8.94
Open Price
$9.60
Volume
4.15K
52 Week High
$12.74
52 Week Low
$8.94

OPT Earnings

-$5.50
-$2.66
$0.17
$3.01
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 10, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure